QUICK AND ACCURATE DIAGNOSIS IS THE BASIS FOR EFFECTIVE TREATMENT
WE DEVELOP MODERN MEDICAL DIAGNOSTICS TO PROTECT HEALTH AND LIFE
The innovative products devised and developed by Scope Fluidics are a response to the immediate needs of the healthcare system, where fast and reliable diagnostics allows for accurate diagnosis, and thus effective treatment, of bacterial and viral infections.
Together with medical staff, we define real problems
and propose solutions based on the possibilities offered by advanced technologies.
Our systems represent a real change that contributes to improving the quality of health and protection of patients’ lives. It is also a way to reduce the length of treatment and minimize its costs.
ACCURATE DIAGNOSIS IN RECORD TIME
The PCR|ONE System is a complete, stand-alone system designed for rapid detection of a wide range of pathogens at the point of care – at doctors’ offices, hospital emergency rooms or other locations where efficient and accurate patient diagnosis is crucial.
The system offers easy-to-use, single-use clinical sample panels that are automatically subjected to detailed diagnostics within minutes.
The PCR|ONE system offers a unique combination of record speed and broad coverage – up to 20 genetic targets per triplicate that can be identified in a single run of the instrument.
Developed within the PCR|ONE system, the SARS-CoV-2 and MRSA/MSSA panels received CE-IVD certification in 2021, allowing them to be marketed in Europe. They offer the most reliable, genetic method of virus and bacterial detection in a very short time. They offer the most reliable genetic method of detecting viruses and bacteria in a very short time.
Self-contained, fast, fully automatic system for the recognition of viruses and bacteria allows you to obtain test results in a remarkably short time – just a few minutes!
The combination of ease of use and speed makes PCR|ONE an ideal solution for customers such as:
THE ANSWER TO ONE OF THE GREATEST CHALLENGES OF MODERN MEDICINE
The increasing resistance of microorganisms to drugs is one of the most serious threats to global health. Scope Fluidics responds to this challenge with an innovative system which makes it possible to gain full knowledge of resistance mechanisms and the sensitivity of bacteria to all available antibiotics.
The results of this work make it possible to implement effective therapy in patients, reduce complications after infections and reduce treatment and hospitalisation costs.
BacterOMIC takes antibiotic susceptibility testing (AST) to the next level by offering quantitative assessment of all clinically relevant antibiotics and identification of synergistic antibiotic pairs.
The first fully automated system designed to test all relevant antibiotics in a single assay and to test combinations of antibiotics!
BacterOMIC addresses the needs of such institutions as: